Bloomberg publishes analysis of the current issues with orphan drug pricing

April 9, 2013 | By Márcio Barra

Not really a news update, just wanted to direct people to this excellent analysis of the current issues of orphan drug pricing that Bloomberg has published. I addressed some of the topics in my Orphan Drug Market series, but this article is a more in depth look of how austerity stricken Europe might have reached the breaking point in the orphan’s drugs through-the-roof prices,  expensive reimbursement schemes and overall sustainability of each Member State health system. It definitely warrants a careful read.

Click here for the Bloomberg article

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: